会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Fused-ring amino-pyrazines as bradycardiac agents
    • 稠环氨基吡嗪作为心动过缓剂
    • US4409220A
    • 1983-10-11
    • US297024
    • 1981-08-27
    • Rudolf HurnausGerhart GrissRobert SauterWolfgang GrellWalter KobingerLudwig Pichler
    • Rudolf HurnausGerhart GrissRobert SauterWolfgang GrellWalter KobingerLudwig Pichler
    • A61K31/495A61K31/55A61P9/02A61P9/06A61P9/12A61P25/02C07D471/04C07D487/04
    • C07D471/04C07D487/04
    • Compounds of the formula ##STR1## wherein A and B, which may be the same or different, each represent methylene, (alkyl of 1 to 3 carbon atoms)-methylene, ethylene or (alkyl of 1 to 3 carbon atoms)-ethylene;R.sub.1 is hydrogen, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, alkenyl of 3 to 6 carbon atoms, phenyl-(alkyl of 1 to 3 carbon atoms), halophenyl-(alkyl of 1 to 3 carbon atoms), alkanoyl of 1 to 3 carbon atoms, phenyl-(alkanoyl of 1 to 3 carbon atoms), halophenyl-(alkanoyl of 1 to 3 carbon atoms), alkoxycarbonyl of 2 to 4 carbon atoms, aralkoxycarbonyl of 8 to 10 carbon atoms or phenyl;one of R.sub.2 and R.sub.3 is amino and the other is hydrogen, chlorine, bromine, alkyl of 1 to 3 carbon atoms, alkoxy of 1 to 3 carbon atoms, alkoxycarbonyl of 2 to 4 carbon atoms, phenyl or halophenyl;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.
    • 其中A和B可以相同或不同,各自表示亚甲基,(1至3个碳原子的烷基) - 亚甲基,亚乙基或(1至3个碳原子的烷基) - 亚乙基; R 1是氢,1至6个碳原子的烷基,3至7个碳原子的环烷基,3至6个碳原子的烯基,苯基 - (1至3个碳原子的烷基),卤代苯基 - (1至3个碳原子的烷基 ),1〜3个碳原子的烷酰基,1〜3个碳原子的苯基 - (烷酰基),1〜3个碳原子的卤代苯基 - (烷酰基),2〜4个碳原子的烷氧基羰基,8〜10个碳原子的芳烷氧羰基, 苯基; R2和R3中的一个是氨基,另一个是氢,氯,溴,1至3个碳原子的烷基,1至3个碳原子的烷氧基,2至4个碳原子的烷氧基羰基,苯基或卤代苯基; 和无毒的,药学上可接受的酸加成盐。 化合物及其盐可用作心动过缓。
    • 3. 发明授权
    • 2-Phenyl-pyrimidones
    • 2-苯基 - 嘧啶酮
    • US4379788A
    • 1983-04-12
    • US327348
    • 1981-12-04
    • Joachim HeiderVolkhard AustelWolfgang EberleinRudolf KadatzChristian Lillie
    • Joachim HeiderVolkhard AustelWolfgang EberleinRudolf KadatzChristian Lillie
    • C07D239/88A61K31/513A61P9/00C07D213/82C07D239/91C07D265/22C07D471/04C07D498/04A61K31/505
    • C07D213/82C07D239/91C07D265/22C07D471/04
    • Compounds of the formula ##STR1## wherein A and B, together with each other and the respective carbon atoms to which they are attached, form a phenyl or pyridine ring;R.sub.1 is hydrogen, halogen, amino, nitro, alkyl of 1 to 3 carbon atoms or alkoxy of 1 to 3 carbon atoms;R.sub.2 is hydrogen or alkoxy of 1 to 3 carbon atoms;D is alkylene of 3 to 4 carbon atoms or hydroxy(alkylene of 3 to 4 carbon atoms);R.sub.3 and R.sub.5, which may be identical to or different from each other, are each hydrogen or alkyl of 1 to 3 carbon atoms;R.sub.4 is hydrogen or alkoxy of 1 to 3 carbon atoms; andR.sub.6 is straight or branched alkyl of 1 to 6 carbon atoms or --E--R.sub.7 ;where E is straight alkylene of 2 to 4 carbon atoms or hydroxy-substituted straight alkylene of 2 to 4 carbon atoms, andR.sub.7 is ##STR2## where R.sub.8 and R.sub.9 are each hydrogen, alkyl of 1 to 3 carbon atoms or alkoxy of 1 to 3 carbon atoms;and non-toxic, pharmacologically acceptable acid addition salts thereof formed with inorganic or organic acids; the compounds as well as their salts are useful as hypotensives, antiarrhythmics and .beta.-receptor-blockers.
    • 其中A和B与它们相连的相互连接的碳原子一起形成苯基或吡啶环; R 1是氢,卤素,氨基,硝基,1至3个碳原子的烷基或1至3个碳原子的烷氧基; R2是氢或1〜3个碳原子的烷氧基; D是3至4个碳原子的亚烷基或羟基(3至4个碳原子的亚烷基); R 3和R 5可以相同或不同,分别为氢或1-3个碳原子的烷基; R4是氢或1〜3个碳原子的烷氧基; R6是1-6个碳原子的直链或支链烷基或-E-R7; 其中E是2至4个碳原子的直链亚烷基或2至4个碳原子的羟基取代的直链亚烷基,并且R 7是R 8和R 9各自为氢,1至3个碳原子的烷基或1至 3个碳原子; 和与无机或有机酸形成的无毒的,药学上可接受的酸加成盐; 化合物及其盐可用作低血糖,抗心律失常药和β-受体阻滞剂。
    • 4. 发明授权
    • Cephalosporins
    • 头孢菌素
    • US4362725A
    • 1982-12-07
    • US305953
    • 1981-09-28
    • Bernd WetzelEberhard WoitunWolfgang ReuterRoland MaierUwe LechnerHanns Goeth
    • Bernd WetzelEberhard WoitunWolfgang ReuterRoland MaierUwe LechnerHanns Goeth
    • A01N43/86A61K20060101A61K31/545A61K31/546A61P31/04C07D20060101C07D501/00C07D501/36C07D501/46C07D501/56C07D501/57
    • C07D501/36Y02P20/55
    • Compounds of the formula ##STR1## wherein A is phenyl, 4-hydroxy-phenyl, 2-thienyl, 2-furyl or 3,4-dihydroxy-phenyl;Y is hydrogen or methoxy;Het is 4H-5,6-dioxo-1,2,4-triazin-3-yl,4-methyl-5,6-dioxo-1,2,4-triazin-3-yl,2-methyl-5,6-dioxo-1,2,4-triazin-3-yl,1-vinyl-tetrazol-5-yl, 1-allyl-tetrazol-5-yl or ##STR2## where n is an integer from 1 to 3, inclusiveR.sub.1 is hydroxyl, amino, dimethylamino, acetylamino, aminocarbonyl, aminocarbonylamino, aminosulfonyl, aminosulfonylamino, methylcarbonyl, methylsulfonylamino, cyano, hydroxysulfonylamino, methylsulfonyl, methylsulfinyl, a carboxylic acid group or a sulfonic acid group, and--(CH.sub.2).sub.n --R.sub.1 may also be alkyl of 2 to 4 carbon atoms or 2,3-dihydroxy-propyl;R is cyclopropyl, 4'-hydroxycyclohexyl-amino ##STR3## where R.sub.2 is straight or branched, saturated or unsaturated hydrocarbyl of 1 to 4 carbon atoms or cycloalkyl of 3 to 6 carbon atoms;G is hydroxyl, aminocarbonyl, aminosulfonyl, aminocarbonylamino, acetylamino, methylsulfonylamino, methylsulfinyl or methylsulfonyl;m is 0 or 1; andR.sub.3 and R.sub.4, which may be identical to or different from each other, are each hydrogen, chlorine, fluorine, hydroxyl, methoxy, acetylamino, aminocarbonylamino, nitro, acetyl, methylcarbonyloxy, methoxycarbonyl, aminocarbonyl, cyano, methylsulfinyl, methylsulfonyl, aminosulfonyl, methylaminosulfonyl or methyl; andE is hydrogen or a protective group which is easily removable in vitro or in vivo;and, when E is hydrogen, non-toxic, pharmacologically acceptable salts thereof; the compounds as well as their salts are useful as antibiotics.
    • 其中A是苯基,4-羟基 - 苯基,2-噻吩基,2-呋喃基或3,4-二羟基 - 苯基的式IMA化合物; Y是氢或甲氧基; Het是4H-5,6-二氧代-1,2,4-三嗪-3-基,4-甲基-5,6-二氧代-1,2,4-三嗪-3-基,2-甲基-5- 6-二氧代-1,2,4-三嗪-3-基,1-乙烯基 - 四唑-5-基,1-烯丙基 - 四唑-5-基或其中n是1至3的整数,包括1和3 R 1是羟基,氨基,二甲基氨基,乙酰氨基,氨基羰基,氨基羰基氨基,氨基磺酰基,氨基磺酰基氨基,甲基羰基,甲基磺酰基氨基,氰基,羟基磺酰基氨基,甲磺酰基,甲基亚磺酰基,羧酸基或磺酸基,和 - (CH 2)n -R 具有2至4个碳原子的烷基或2,3-二羟基丙基; 其中R 2是具有1至4个碳原子的直链或支链,饱和或不饱和的烃基或3至6个碳原子的环烷基; R 2是环丙基,4'-羟基环己基氨基, G是羟基,氨基羰基,氨基磺酰基,氨基羰基氨基,乙酰氨基,甲基磺酰基氨基,甲基亚磺酰基或甲基磺酰基; m为0或1; 可以相同或不同的R 3和R 4各自为氢,氯,氟,羟基,甲氧基,乙酰氨基,氨基羰基氨基,硝基,乙酰基,甲基羰基氧基,甲氧基羰基,氨基羰基,氰基,甲基亚磺酰基,甲基磺酰基,氨基磺酰基, 甲基氨基磺酰基或甲基; E是氢或在体外或体内容易除去的保护基; 并且当E是氢时,其无毒的药学上可接受的盐; 化合物及其盐可用作抗生素。
    • 5. 发明授权
    • Pyridazinone-substituted benzimidazoles and salts
    • 哒嗪酮取代的苯并咪唑和盐
    • US4361563A
    • 1982-11-30
    • US259537
    • 1981-05-01
    • Volkhard AustelJoachim HeiderWolfgang EberleinWilli DiederenWalter Haarmann
    • Volkhard AustelJoachim HeiderWolfgang EberleinWilli DiederenWalter Haarmann
    • A61K31/50C07D235/18C07D237/04C07D403/04
    • C07D237/04A61K31/50C07D235/18Y10S514/822
    • Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen; trifluoromethyl; alkyl of 1 to 11 carbon atoms; cycloalkyl of 3 to 7 carbon atoms; hydroxyl; alkoxy of 1 to 6 carbon atoms; mercapto; (alkyl of 1 to 6 carbon atoms)-mercapto; phenyl-(alkyl of 1 to 3 carbon atoms); phenyl; or mono-, di- or tri-substituted phenyl, where the substituents, which may be identical to or different from each other, are each halogen, alkyl of 1 to 4 carbon atoms, (alkyl of 1 to 6 carbon atoms)-sulfinyl, hydroxyl, alkoxy of 1 to 6 carbon atoms, mercapto or (alkyl of 1 to 6 carbon atoms)-mercapto;R.sub.2 is hydrogen, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl-(alkyl of 1 to 3 carbon atoms); andR.sub.3 is alkyl of 1 to 6 carbon atoms; optically active antipodes thereof; and non-toxic, pharmaceutically acceptable acid addition salts of said compounds or of said optically active antiposed. The compounds are useful as cardiotonics and antithrombotics.
    • 其中R 1是氢的式IMAMA的化合物; 三氟甲基 1至11个碳原子的烷基; 3至7个碳原子的环烷基; 羟; 1至6个碳原子的烷氧基; 巯基 (1-6个碳原子的烷基) - 巯基; 苯基 - (1至3个碳原子的烷基); 苯基; 或单取代,二取代或三取代的苯基,其中可以相同或不同的取代基各自为卤素,具有1至4个碳原子的烷基,(1至6个碳原子的烷基) - 亚磺酰基 ,羟基,1至6个碳原子的烷氧基,巯基或(1至6个碳原子的烷基) - 巯基; R2是氢,1至6个碳原子的烷基,3至6个碳原子的环烷基或苯基 - (1至3个碳原子的烷基); 且R 3为1至6个碳原子的烷基; 光学活性对映体; 和所述化合物或所述光学活性药物的无毒的药学上可接受的酸加成盐。 这些化合物可用作强心剂和抗血栓药物。